Skip to main content
. Author manuscript; available in PMC: 2015 Oct 1.
Published in final edited form as: Prostaglandins Other Lipid Mediat. 2014 Sep 26;0:62–68. doi: 10.1016/j.prostaglandins.2014.09.002

Figure 5.

Figure 5

Effect of 10−5M EP3 antagonist (EP3i) on PGE2-stimulation of PAI-1 in NVF as measured by real time RT-PCR. Cells were pre-treated with antagonist for 1 hr prior to 24 hr treatment with PGE2. Expression of PAI-1 was corrected to GAPDH as a loading control. Statistical significance: *** p < 0.0001 versus vehicle treatment, ++ p < 0.01 versus PGE2 alone, n = 3-4.